Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesClinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events
Best Practice & Research Clinical Endocrinology & Metabolism, 09/21/09
Ahren B – Inhibition of dipeptidyl peptidase–4 (DPP–4) is a novel oral treatment for type 2 diabetes. DPP–4 inhibition may also be used in combination with sulphonylurea and thiazolidinediones and potentially also in combination with insulin. The durability and long–term safety of DPP–4 inhibitiors remain to be established.
Related Articles
Sitagliptin 100mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement
Current Medical Research and Opinion, 10/08/09
Relevance Score: 89%
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation
Journal of Diabetes and its Complications, 10/29/09
Relevance Score: 85%
Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 82%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/17/09
Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 Diabetes
The American Journal of the Medical Sciences, 12/17/09
Ileal Interposition with Sleeve Gastrectomy for Control of Type 2 Diabetes
Diabetes Technology & Therapeutics, 12/17/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/17/09
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor